Does RISANKIZUMAB-RZAA Cause Hepatitis c? 14 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Hepatitis c have been filed in association with RISANKIZUMAB-RZAA. This represents 0.0% of all adverse event reports for RISANKIZUMAB-RZAA.
14
Reports of Hepatitis c with RISANKIZUMAB-RZAA
0.0%
of all RISANKIZUMAB-RZAA reports
0
Deaths
2
Hospitalizations
How Dangerous Is Hepatitis c From RISANKIZUMAB-RZAA?
Of the 14 reports, 2 (14.3%) required hospitalization, and 1 (7.1%) were considered life-threatening.
Is Hepatitis c Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Hepatitis c?
RIBAVIRIN (2,130)
SOFOSBUVIR (1,662)
LEDIPASVIR\SOFOSBUVIR (1,076)
OXYCODONE (713)
SIMEPREVIR (537)
SOFOSBUVIR\VELPATASVIR (510)
ACETAMINOPHEN\OXYCODONE (499)
ACETAMINOPHEN\HYDROCODONE (497)
PEGINTERFERON ALFA-2A (482)
HYDROMORPHONE (430)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Hepatitis c Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA